BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28043662)

  • 1. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
    Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
    Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
    Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
    Liu YH; Liu Y; Zhou YL; He PC; Yu DQ; Li LW; Xie NJ; Guo W; Tan N; Chen JY
    Am J Cardiol; 2016 Jun; 117(12):1896-903. PubMed ID: 27161818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention.
    Ji L; Su X; Qin W; Mi X; Liu F; Tang X; Li Z; Yang L
    Nephrology (Carlton); 2015 Aug; 20(8):544-51. PubMed ID: 25706048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score.
    Araujo GN; Pivatto Junior F; Fuhr B; Cassol EP; Machado GP; Valle FH; Bergoli LC; Wainstein RV; Polanczyk CA; Wainstein MV
    Cardiovasc Interv Ther; 2018 Jul; 33(3):224-231. PubMed ID: 28540634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Chen YL; Fu NK; Xu J; Yang SC; Li S; Liu YY; Cong HL
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E8-16. PubMed ID: 23907993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions.
    Chou RH; Huang PH; Hsu CY; Leu HB; Huang SS; Huang CC; Chen JW; Lin SJ
    J Formos Med Assoc; 2016 Jul; 115(7):501-9. PubMed ID: 26830105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Park SH; Jeong MH; Park IH; Choi JS; Rhee JA; Kim IS; Kim MC; Cho JY; Sim DS; Hong YJ; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Int J Cardiol; 2016 Jun; 212():100-6. PubMed ID: 27045874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between prophylactic hydration volume and risk of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Cui T; Zhao J; Bei W; Li H; Tan N; Wu D; Wang K; Guo X; Liu Y; Duan C; Chen S; Lin K; Liu Y
    Cardiol J; 2017; 24(6):660-670. PubMed ID: 28394010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S
    Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
    Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients.
    Gao YM; Li D; Cheng H; Chen YP
    Clin Exp Nephrol; 2014 Dec; 18(6):892-8. PubMed ID: 24515307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random forest for prediction of contrast-induced nephropathy following coronary angiography.
    Liu Y; Chen S; Ye J; Xian Y; Wang X; Xuan J; Tan N; Li Q; Chen J; Ni Z
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):983-991. PubMed ID: 32285318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mehran contrast nephropathy risk score: Is it still useful 10 years later?
    Abellás-Sequeiros RA; Raposeiras-Roubín S; Abu-Assi E; González-Salvado V; Iglesias-Álvarez D; Redondo-Diéguez A; González-Ferreiro R; Ocaranza-Sánchez R; Peña-Gil C; García-Acuña JM; González-Juanatey JR
    J Cardiol; 2016 Mar; 67(3):262-7. PubMed ID: 26169247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canada Acute Coronary Syndrome Score: A Preprocedural Risk Score for Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Liu YH; Jiang L; Duan CY; He PC; Liu Y; Tan N; Chen JY
    Angiology; 2017 Oct; 68(9):782-789. PubMed ID: 28135823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çınar T; Tanık VO; Aruğaslan E; Karabağ Y; Çağdaş M; Rencüzoğulları İ; Keskin M
    Cardiovasc Interv Ther; 2019 Jul; 34(3):207-215. PubMed ID: 30191494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.
    Araujo GN; Wainstein MV; McCabe JM; Huang PH; Govindarajulu US; Resnic FS
    J Interv Cardiol; 2016 Oct; 29(5):447-453. PubMed ID: 27377243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
    Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
    Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.